Participated · Series A · Sep 2024

Segmed provides real-world medical imaging data to life-sciences, health care and technology firms via a proprietary platform that acquires, de-identifies, standardizes, and delivers imaging studies. The company supports biopharmaceutical R&D, AI/ML development and real-world imaging data (RWiD) use cases. Segmed partners with health-care locations and imaging clinics across five continents to source the studies researchers and developers need. Led by CEO Martin Willemink, the company intends to use the Series A proceeds to further expand its medical imaging solutions for AI development and real-world evidence. Financially, Segmed raised $10.4M in a Series A and previously received financing from Flashpoint Growth Debt Fund in 2023. The company is headquartered in Palo Alto, California. Segmed offers a cloud-based real-world imaging platform, Segmed Insight, that enables medical researchers and AI developers to search, view studies and reports matching their criteria, and construct custom datasets. After placing an order users receive data in hand within days. The company has signed partnerships with healthcare systems, hospitals and imaging clinics across 1,000 locations on five continents. Led by CEO Martin Willemink, Segmed is based in Palo Alto, California. It raised $5.2M in a Seed+ round and has now raised more than $10M to date. The company intends to use the funds to accelerate growth, expand operations and broaden its business reach. Segmed is a secure, cloud-based platform that curates medical data by anonymizing, standardizing and labeling it to accelerate innovation in healthcare. Led by co-founder and CEO Cailin Hardell, the company partners with diverse healthcare providers around the world to source data. It standardizes and indexes medical data via a sequence of proprietary algorithms and enables customers to build customized datasets. Segmed positions itself as a shop for rapid, low-cost data aggregation and standardization for medical AI development. The company maintains strict HIPAA compliance and only uses and shares data that is fully anonymized. Financially, Segmed closed a $2M seed funding round in March 2020 to support its platform.

Participated · Seed · Aug 2021

Cardiomatics provides a cloud-based AI tool that automates ECG interpretation and generates reports in minutes, detecting roughly 20 heart abnormalities. The startup announced a $3.2M seed raise (plus a $1M non-equity grant) to expand use of its ECG-reading automation technology. Its software integrates with more than 25 ECG monitoring devices and is used by over 700 customers across 10+ countries, having commercially analysed more than 3 million hours of ECG signals. The company says its development dataset contains over 10 billion heartbeats from approximately 100,000 patients, with 90% of data used for training and 10% for validation and monthly algorithm checks; clients also check performance in clinical practice. Cardiomatics received European medical device certification in 2018 and says it closely monitors evolving EU medical-device and AI regulations. It plans to use the seed proceeds for product development, scaling its AI technology, expanding in existing markets and preparing to enter new markets, including pursuing FDA certification and US entry.

Participated · Equity · Oct 2020

D-Orbit leverages its experience with flown orbital transfer vehicles to offer managed orbital logistics services, including last-mile payload delivery, orbital transfer and hosted services on a subscription basis. The company is pursuing a Deorbit-as-a-Service (DaaS) model intended to let customers define mission objectives while D-Orbit provides the vehicle and operations, aiming to reduce time and cost compared with buying dedicated hardware. Through the DIU/SDA award, D-Orbit Space will demonstrate rendezvous, docking and other on-orbit capabilities that could enable refueling, repair, inspection and repositioning missions in low Earth orbit. For the DaaS demonstration D-Orbit Space will lead the effort with partners TransAstra and Falcon Exodynamics. The company positions the service model as scalable and resilient to meet repeated government mission demands.